| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | INCY | United States | $95.91 | $4,813,105,000.00 | Buy | 21 | 1993 |
#2 | MARA | United States | $11.83 | $919,173,000.00 | Buy | 14 | N/A |
#3 | CWK | United States | $15.58 | $10,003,900,000.00 | Buy | 8 | 2018 |
#4 | T | United States | $24.33 | $124,480,000,000.00 | Buy | 20 | N/A |
#5 | CWEN | United States | $32.65 | $1,375,000,000.00 | Strong Buy | 8 | 2013 |
#6 | AMX | Mexico | $21.38 | $51,012,503,011.00 | Buy | 6 | 2001 |
#7 | CTRE | United States | $35.85 | $428,478,000.00 | Buy | 6 | N/A |
#8 | TME | China | $18.20 | $4,455,416,345.00 | Strong Buy | 5 | 2018 |
#9 | BZ | China | $20.24 | $1,125,491,208.00 | Strong Buy | 4 | 2021 |
#10 | HALO | United States | $61.89 | $1,242,852,000.00 | Buy | 12 | N/A |
#11 | BSX | United States | $91.48 | $19,349,000,000.00 | Strong Buy | 19 | 1992 |
#12 | FE | United States | $44.07 | $14,283,000,000.00 | Buy | 14 | N/A |
#13 | ACM | United States | $99.79 | $16,139,622,000.00 | Strong Buy | 10 | 2007 |
#14 | DOCS | United States | $43.99 | $621,329,000.00 | Buy | 21 | 2021 |
#15 | TTD | United States | $37.04 | $2,790,505,000.00 | Buy | 35 | 2016 |
#16 | DX | United States | $13.53 | $230,447,000.00 | Buy | 4 | N/A |
#17 | NFLX | United States | $93.97 | $43,378,787,000.00 | Buy | 35 | 2002 |
#18 | PPL | United States | $33.39 | $8,979,000,000.00 | Buy | 10 | N/A |
#19 | OHI | United States | $43.58 | $1,150,200,000.00 | Buy | 10 | N/A |
#20 | BKR | United States | $47.40 | $27,711,000,000.00 | Strong Buy | 18 | N/A |
#21 | OGE | United States | $42.56 | $3,294,800,000.00 | Buy | 9 | N/A |
#22 | CGNX | United States | $36.79 | $971,705,000.00 | Buy | 12 | 1989 |
#23 | LMAT | United States | $83.34 | $240,866,000.00 | Buy | 6 | 2006 |
#24 | LNT | United States | $64.89 | $4,274,000,000.00 | Buy | 8 | N/A |
#25 | AEE | United States | $97.11 | $8,635,000,000.00 | Buy | 12 | N/A |
#26 | DINO | United States | $49.44 | $26,905,000,000.00 | Buy | 12 | N/A |
#27 | WTRG | United States | $37.64 | $2,379,887,000.00 | Buy | 7 | N/A |
#28 | AMRC | United States | $32.12 | $1,883,767,000.00 | Buy | 9 | 2010 |
#29 | NI | United States | $41.57 | $6,327,100,000.00 | Buy | 9 | N/A |
#30 | VIV | Brazil | $12.24 | $10,989,199,704.00 | Buy | 4 | 1998 |
#31 | MDT | Ireland | $99.67 | $34,758,000,000.00 | Buy | 18 | N/A |
#32 | OGS | United States | $76.97 | $2,368,759,000.00 | Buy | 9 | N/A |
#33 | PSN | United States | $65.75 | $6,494,748,000.00 | Strong Buy | 13 | 2019 |
#34 | ORLY | United States | $93.97 | $17,463,279,000.00 | Strong Buy | 18 | 1993 |
#35 | CNP | United States | $37.23 | $9,114,000,000.00 | Buy | 12 | N/A |
#36 | SR | United States | $81.97 | $2,476,400,000.00 | Buy | 11 | N/A |
#37 | PSTG | United States | $75.94 | $3,483,782,000.00 | Buy | 19 | 2015 |
#38 | PEG | United States | $78.87 | $11,718,000,000.00 | Buy | 13 | N/A |
#39 | CYTK | United States | $60.69 | $87,211,000.00 | Strong Buy | 15 | 2004 |
#40 | ZLAB | China | $17.82 | $441,629,000.00 | Buy | 6 | 2017 |
#41 | MRVL | United States | $89.12 | $7,793,300,000.00 | Buy | 32 | 2000 |
#42 | QURE | Netherlands | $19.68 | $15,751,000.00 | Strong Buy | 12 | 2007 |
#43 | BEPC | United States | $39.05 | $3,828,000,000.00 | Buy | 4 | N/A |
#44 | LENZ | United States | $24.52 | $17,500,000.00 | Strong Buy | 4 | 2021 |
#45 | W | United States | $99.34 | $12,241,000,000.00 | Buy | 24 | 2014 |
#46 | TAC | Canada | $14.43 | $1,783,342,546.00 | Strong Buy | 4 | N/A |
#47 | LIF | United States | $69.13 | $459,031,000.00 | Strong Buy | 6 | N/A |
#48 | S | United States | $15.00 | $955,646,000.00 | Buy | 29 | 2021 |
#49 | SOUN | United States | $12.02 | $148,404,000.00 | Buy | 7 | N/A |
#50 | LEGN | United States | $23.02 | $909,045,000.00 | Strong Buy | 13 | 2020 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (December 12, 2025) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.